Literature DB >> 17373667

Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.

Angela Barrett1, Samantha Santangelo, Keith Tan, Steve Catchpole, Kevin Roberts, Bradley Spencer-Dene, Debbie Hall, Angelo Scibetta, Joy Burchell, Eric Verdin, Paul Freemont, Joyce Taylor-Papadimitriou.   

Abstract

The PLU-1/JARID1B nuclear protein, which is expressed in a high proportion of breast cancers, but shows restricted expression elsewhere, belongs to the ARID family of proteins, known to play important roles in development, differentiation, transcriptional regulation and chromatin remodeling. PLU-1/JARID1B is a strong transcriptional repressor, and here we show that the protein localizes in MAD bodies when cotransfected with class IIa histone deacetylases (HDACs) or N-CoR. Direct binding to class I and class IIa HDACs is demonstrated, while the interaction with N-CoR appears to be indirect. The domains involved in the HDAC4-PLU-1/JARID1B interaction were investigated in detail, and the data show that 2 PHD domains in PLU-1/JARID1B, which are involved in transcriptional repression, are also crucial for binding to a domain in the 5' region of HDAC4, overlapping the MEF-2 binding region. Physiological relevance of this interaction in the mammary gland is suggested from the observation that HDAC4 and PLU-1/JARID1B are coexpressed in the pregnant and involuting mouse mammary gland and are both silenced at lactation. Significantly, the expression of both proteins is seen in breast cancers. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373667     DOI: 10.1002/ijc.22673

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  51 in total

Review 1.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 2.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

Review 3.  Atypical fetal development: Fetal alcohol syndrome, nutritional deprivation, teratogens, and risk for neurodevelopmental disorders and psychopathology.

Authors:  Michael K Georgieff; Phu V Tran; Erik S Carlson
Journal:  Dev Psychopathol       Date:  2018-08

4.  Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).

Authors:  Ping-Pui Wong; Fabrizio Miranda; KaYi V Chan; Chiara Berlato; Helen C Hurst; Angelo G Scibetta
Journal:  Mol Cell Biol       Date:  2012-02-27       Impact factor: 4.272

Review 5.  Selective class IIa HDAC inhibitors: myth or reality.

Authors:  Eros Di Giorgio; Enrico Gagliostro; Claudio Brancolini
Journal:  Cell Mol Life Sci       Date:  2014-09-05       Impact factor: 9.261

6.  JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.

Authors:  Nicole D Facompre; Kayla M Harmeyer; Xavier Sole; Sheheryar Kabraji; Zachary Belden; Varun Sahu; Kelly Whelan; Koji Tanaka; Gregory S Weinstein; Kathleen T Montone; Alexander Roesch; Phyllis A Gimotty; Meenhard Herlyn; Anil K Rustgi; Hiroshi Nakagawa; Sridhar Ramaswamy; Devraj Basu
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

Review 7.  Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Authors:  James Larkin; Xin Yi Goh; Marcus Vetter; Lisa Pickering; Charles Swanton
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

8.  Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.

Authors:  Mike Ran Zou; Jian Cao; Zongzhi Liu; Sung Jin Huh; Kornelia Polyak; Qin Yan
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

Review 9.  HDAC4: mechanism of regulation and biological functions.

Authors:  Zhengke Wang; Gangjian Qin; Ting C Zhao
Journal:  Epigenomics       Date:  2014-02       Impact factor: 4.778

Review 10.  Keeping an open mind: highlights and controversies of the breast cancer stem cell theory.

Authors:  Mansi Shah; Cinzia Allegrucci
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.